Eli Lilly & Co. (LLY), Sigilon Therapeutics Announce Pact to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes
Tweet Send to a Friend
Eli Lilly and Company (NYSE: LLY) and Sigilon Therapeutics today announced a global collaboration to develop encapsulated cell therapies ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
